MoneyWorks4Me

Auro Laboratories - Quaterly Results

09 Aug 2024 Evaluate
The sales for the June 2024 quarter moved down -43.83% to Rs. 57.20 millions as compared to Rs. 101.83 millions during the year ago period.A humble growth in net profit of 6.36% reported in the quarter ended June 2024 to Rs. 7.53  millions from Rs. 7.08 millions.Operating profit surged to 15.26 millions from the corresponding previous quarter of 15.18 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 57.20 101.83 -43.83 57.20 101.83 -43.83 536.35 528.94 1.40
Other Income 2.03 3.65 -44.38 2.03 3.65 -44.38 15.04 9.41 59.83
PBIDT 15.26 15.18 0.53 15.26 15.18 0.53 121.74 53.34 128.23
Interest 2.50 2.67 -6.37 2.50 2.67 -6.37 7.36 8.14 -9.58
PBDT 12.76 12.51 2.00 12.76 12.51 2.00 114.38 45.20 153.05
Depreciation 2.70 2.70 0.00 2.70 2.70 0.00 10.92 10.74 1.68
PBT 10.06 9.81 2.55 10.06 9.81 2.55 103.46 34.46 200.23
TAX 2.53 2.73 -7.33 2.53 2.73 -7.33 25.54 10.04 154.38
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -1.87 0.03 -6333.33
PAT 7.53 7.08 6.36 7.53 7.08 6.36 77.92 24.42 219.08
Equity 62.32 62.32 0.00 62.32 62.32 0.00 62.32 62.32 0.00
PBIDTM(%) 26.68 14.91 78.96 26.68 14.91 78.96 22.70 10.08 125.08
Peers
Company Name CMP
Sun Pharma. Inds. 1820.00
Dr. Reddys Labs. 1236.00
Cipla 1350.00
Lupin 2042.00
Zydus Lifesciences 1163.35
View more..